ELRIG Advances in Cell-based Screening in Drug Discovery 2026

This event is essential for professionals across the cell-based discovery continuum who are actively preparing for an AI-driven future.

Through collaborative dialogue, we aim to help this community rework early discovery from animal-gated milestones to human-first decision making. This new blueprint needs us to deliberate on how our hit-to-lead processes should change, where cells should replace animals, and how AI can enhance the predictive accuracy of our efforts to deliver transformative therapies.

Join the Dotmatics team at Booth #29 to be part of this conversation.

Sign up to meet us at the booth!